| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ACADACADIA Pharmaceuticals Inc. | 4.54B | 26.86 | 19.75 | 31.85% | 24.94% | 28.47% | 3.46% | 0.07 |
| JAZZJazz Pharmaceuticals plc | 10.38B | 170.81 | 19.75 | 6.12% | -8.86% | -9.31% | 12.99% | 1.51 |
| CPRXCatalyst Pharmaceuticals, Inc. | 2.85B | 23.17 | 17.69 | 23.49% | 37.63% | 23.64% | 8.4% | 0.00 |
| HRMYHarmony Biosciences Holdings, Inc. | 2.08B | 36.04 | 14.36 | 22.8% | 22.48% | 22.23% | 10.53% | 0.28 |
| ALKSAlkermes plc | 5.06B | 30.62 | 14.11 | -6.36% | 22.27% | 19.55% | 8.02% | 0.05 |
| PRTCPureTech Health plc | 458.47M | 18.97 | 9.49 | 44.98% | -495.91% | -8.53% | 0.05 | |
| LBRXLB Pharmaceuticals Inc Common Stock | 489.79M | 19.36 | -1.09 | |||||
| NMRANeumora Therapeutics, Inc. Common Stock | 365.37M | 2.15 | -1.41 | -178.79% | 0.01 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 11.74M | 4.43M | 650K | 16.37M | 8.69M | 8.34M | 9.98M | 2.09M | 3.33M | 4.83M |
| Revenue Growth % | 4.83% | -0.62% | -0.85% | 24.19% | -0.47% | -0.04% | 0.2% | -0.79% | 0.59% | 0.45% |
| Cost of Goods Sold | 740K | 1.57M | 71.03M | 77.4M | 85.85M | 0 | 110.47M | 152.43M | 4.93M | 0 |
| COGS % of Revenue | 0.06% | 0.35% | 109.28% | 4.73% | 9.88% | - | 11.07% | 72.93% | 1.48% | - |
| Gross Profit | 11M | 2.86M | -70.39M | -61.03M | -77.16M | 8.34M | -100.49M | -136.81M | -1.6M | 1.26M |
| Gross Margin % | 0.94% | 0.65% | -108.28% | -3.73% | -8.88% | 1% | -10.07% | -65.46% | -0.48% | 0.26% |
| Gross Profit Growth % | 4.47% | -0.74% | -25.6% | 0.13% | -0.26% | 1.11% | -13.05% | -0.36% | 0.99% | 1.78% |
| Operating Expenses | 55.38M | 78.36M | 116.07M | 120.39M | 144.09M | 127.87M | 160.26M | 60.99M | 54.55M | 140.41M |
| OpEx % of Revenue | 4.72% | 17.68% | 178.57% | 7.35% | 16.58% | 15.33% | 16.06% | 29.18% | 16.38% | 29.08% |
| Selling, General & Admin | 18.38M | 37.16M | 46.28M | 24.43M | 34.89M | 26.5M | 30.76M | 35.67M | 48.36M | 27.49M |
| SG&A % of Revenue | 1.57% | 8.39% | 71.2% | 1.49% | 4.02% | 3.18% | 3.08% | 17.07% | 14.52% | 5.69% |
| Research & Development | 13.41M | 41.2M | 71.67M | 57.29M | 65.17M | 61.19M | 81.52M | 116.11M | 96.23M | 54.28M |
| R&D % of Revenue | 1.14% | 9.3% | 110.26% | 3.5% | 7.5% | 7.34% | 8.17% | 55.56% | 28.9% | 11.24% |
| Other Operating Expenses | 448K | 46K | 14K | -278K | 44.03M | 40.19M | 47.98M | -90.79M | -90.04M | 58.64M |
| Operating Income | -43.64M | -73.93M | -115.42M | -104.02M | -135.4M | -119.53M | -150.28M | -197.81M | -146.2M | -136.09M |
| Operating Margin % | -3.72% | -16.68% | -177.57% | -6.35% | -15.58% | -14.33% | -15.06% | -94.64% | -43.9% | -28.19% |
| Operating Income Growth % | -1.5% | -0.69% | -0.56% | 0.1% | -0.3% | 0.12% | -0.26% | -0.32% | 0.26% | 0.07% |
| EBITDA | -42.9M | -72.36M | -113.32M | -101.24M | -128.73M | -112.88M | -143.04M | -188.91M | -141.27M | -132.52M |
| EBITDA Margin % | -3.65% | -16.33% | -174.34% | -6.18% | -14.82% | -13.53% | -14.33% | -90.39% | -42.42% | -27.45% |
| EBITDA Growth % | -1.53% | -0.69% | -0.57% | 0.11% | -0.27% | 0.12% | -0.27% | -0.32% | 0.25% | 0.06% |
| D&A (Non-Cash Add-back) | 740K | 1.57M | 2.1M | 2.78M | 6.67M | 6.66M | 7.24M | 8.89M | 4.93M | 3.57M |
| EBIT | -51.97M | -76.37M | -70.01M | -68.05M | 481.12M | 56.03M | 19.46M | -197.81M | -16.56M | 33.81M |
| Net Interest Income | -4.09M | -5.62M | -8.46M | -11.45M | 260K | -1.76M | -4.5M | 1.85M | 2.52M | 12.63M |
| Interest Income | 262K | 1.19M | 1.75M | 3.36M | 4.36M | 1.18M | 214K | 5.8M | 16.01M | 22.67M |
| Interest Expense | 4.35M | 6.81M | 10.21M | 14.81M | 4.1M | 2.95M | 4.71M | 3.95M | 13.49M | 10.04M |
| Other Income/Expense | -12.68M | -9.25M | 44.71M | 35.58M | 613.87M | 138.5M | 91.33M | 105.02M | 110.1M | 159.87M |
| Pretax Income | -56.32M | -83.18M | -70.71M | -68.44M | 478.47M | 18.97M | -58.95M | -92.78M | -36.1M | 23.77M |
| Pretax Margin % | -4.8% | -18.77% | -108.79% | -4.18% | 55.07% | 2.27% | -5.91% | -44.39% | -10.84% | 4.92% |
| Income Tax | 1.92M | -1.57M | -14K | 2.22M | 112.41M | 14.4M | 3.76M | -55.72M | 30.52M | -4.01M |
| Effective Tax Rate % | 0.7% | 0.59% | -0.44% | 0.64% | 0.88% | 0.32% | 1.03% | 0.54% | 1.82% | 2.25% |
| Net Income | -39.39M | -48.79M | 30.87M | -43.65M | 421.14M | 5.99M | -60.56M | -50.35M | -65.7M | 53.51M |
| Net Margin % | -3.36% | -11.01% | 47.49% | -2.67% | 48.47% | 0.72% | -6.07% | -24.09% | -19.73% | 11.08% |
| Net Income Growth % | 0.05% | -0.24% | 1.63% | -2.41% | 10.65% | -0.99% | -11.12% | 0.17% | -0.3% | 1.81% |
| Net Income (Continuing) | -58.24M | -81.61M | -57.49M | -70.66M | 335.27M | 4.57M | -62.71M | -37.06M | -66.63M | 27.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -62.07M | -85.25M | -150.31M | -108.53M | -17.64M | -16.21M | -9.37M | 5.37M | -5.83M | -6.77M |
| EPS (Diluted) | -2.10 | -2.10 | 1.10 | -1.60 | 14.40 | 0.20 | -2.10 | -1.80 | -2.40 | 2.00 |
| EPS Growth % | 0.59% | 0% | 1.52% | -2.45% | 10% | -0.99% | -11.5% | 0.14% | -0.33% | 1.83% |
| EPS (Basic) | -2.10 | -2.10 | 1.10 | -1.60 | 14.90 | 0.20 | -2.10 | -1.80 | -2.40 | 2.00 |
| Diluted Shares Outstanding | 18.53M | 22.95M | 23.89M | 27.38M | 29.18M | 29.29M | 28.66M | 28.48M | 27.63M | 26.97M |
| Basic Shares Outstanding | 18.53M | 22.95M | 24.07M | 27.28M | 29.25M | 29.93M | 28.66M | 27.97M | 27.63M | 26.97M |
| Dividend Payout Ratio | - | - | 0% | - | 0% | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 318.2M | 288.15M | 198.11M | 259.79M | 168.84M | 414.35M | 501.81M | 386.19M | 347.2M | 386.26M |
| Cash & Short-Term Investments | 314.53M | 282.37M | 189.67M | 250.88M | 162.45M | 403.88M | 465.71M | 350.1M | 327.14M | 367.31M |
| Cash Only | 134.75M | 62.96M | 72.65M | 117.05M | 132.36M | 403.88M | 465.71M | 149.87M | 191.08M | 280.64M |
| Short-Term Investments | 179.78M | 219.41M | 117.03M | 133.83M | 30.09M | 0 | 0 | 200.23M | 136.06M | 86.67M |
| Accounts Receivable | 706K | 125K | 1.8M | 1.33M | 2.33M | 2.94M | 3.59M | 22.36M | 2.38M | 12.9M |
| Days Sales Outstanding | 21.95 | 10.3 | 1.01K | 29.61 | 97.76 | 128.61 | 131.27 | 3.9K | 260.43 | 975.48 |
| Inventory | 0 | -1.92M | -2.72M | -1.33M | 0 | 0 | 28M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | 92.51 | - | - | - |
| Other Current Assets | 896K | 897K | 927K | 2.2M | 2.12M | 2.12M | -6.24M | 2.12M | 13.37M | 1.64M |
| Total Non-Current Assets | 8.55M | 10.6M | 141.74M | 181.98M | 772.33M | 575.64M | 444.2M | 316.45M | 346.77M | 216.38M |
| Property, Plant & Equipment | 4.52M | 6.92M | 6.86M | 8.32M | 43.84M | 42.87M | 43.94M | 37.24M | 19.36M | 15.13M |
| Fixed Asset Turnover | 2.60x | 0.64x | 0.09x | 1.97x | 0.20x | 0.19x | 0.23x | 0.06x | 0.17x | 0.32x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.87M | 3.52M | 3.31M | 3.08M | 625K | 899K | 987K | 831K | 906K | 601K |
| Long-Term Investments | -179.68M | -219.32M | 14.33M | 35.93M | 695.46M | 531.86M | 398.46M | 60.81M | 325.63M | 200.17M |
| Other Non-Current Assets | 57K | 65K | 117.1M | 134.2M | 32.27M | 531.87M | 399.27M | 278.38M | 879K | 476K |
| Total Assets | 326.75M | 298.75M | 339.85M | 441.76M | 941.18M | 989.99M | 946.01M | 702.65M | 693.97M | 602.63M |
| Asset Turnover | 0.04x | 0.01x | 0.00x | 0.04x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.01x |
| Asset Growth % | 0.43% | -0.09% | 0.14% | 0.3% | 1.13% | 0.05% | -0.04% | -0.26% | -0.01% | -0.13% |
| Total Current Liabilities | 160.52M | 204.08M | 273.86M | 265.76M | 139.2M | 180.92M | 226.13M | 96.89M | 51.37M | 41.39M |
| Accounts Payable | 2.39M | 2.08M | 3.39M | 4.64M | 11.1M | 8.87M | 11.35M | 26.5M | 14.64M | 5.52M |
| Days Payables Outstanding | 1.18K | 482.87 | 17.44 | 21.9 | 47.19 | - | 37.48 | 63.46 | 1.08K | - |
| Short-Term Debt | 4.96M | 6.95M | 7.46M | 12.01M | 1.46M | 26.45M | 5.5M | 7.5M | 3.7M | 4.11M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 0 |
| Other Current Liabilities | 61.29M | 97.62M | 121.04M | 207.08M | 92.45M | -529K | 152.01M | 29.4M | 29.64M | 27.18M |
| Current Ratio | 1.98x | 1.41x | 0.72x | 0.98x | 1.21x | 2.29x | 2.22x | 3.99x | 6.76x | 9.33x |
| Quick Ratio | 1.98x | 1.42x | 0.73x | 0.98x | 1.21x | 2.29x | 2.10x | 3.99x | 6.76x | 9.33x |
| Cash Conversion Cycle | - | - | - | - | - | - | 186.3 | - | - | - |
| Total Non-Current Liabilities | 2.18M | 2.26M | 1.99M | 9.03M | 151.58M | 155.53M | 135.72M | 58.17M | 184.37M | 153.31M |
| Long-Term Debt | 0 | 0 | 0 | 357K | 0 | 14.82M | 14.26M | 10.24M | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 410K | 357K | 34.91M | 32.09M | 29.04M | 24.16M | 18.25M | 14.67M |
| Deferred Tax Liabilities | 0 | 0 | 4.4M | 6.43M | 115.44M | 108.63M | 89.77M | 19.64M | 52.46M | 0 |
| Other Non-Current Liabilities | 1.89M | 2.06M | 1.42M | 876K | 0 | -1K | 2.66M | 4.13M | 113.66M | 138.64M |
| Total Liabilities | 162.7M | 206.34M | 275.85M | 274.79M | 290.78M | 336.45M | 361.86M | 155.06M | 235.74M | 194.7M |
| Total Debt | 4.96M | 6.95M | 7.46M | 12.37M | 39.3M | 76.62M | 52.75M | 46.87M | 25.34M | 22.36M |
| Net Debt | -129.8M | -56.01M | -65.19M | -104.68M | -93.06M | -327.26M | -413.68M | -102.99M | -165.74M | -258.28M |
| Debt / Equity | 0.03x | 0.08x | 0.12x | 0.07x | 0.06x | 0.12x | 0.09x | 0.09x | 0.06x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -10.03x | -10.86x | -11.30x | -7.03x | -33.01x | -40.57x | -31.88x | -50.04x | -10.84x | -13.56x |
| Total Equity | 164.05M | 92.41M | 64M | 166.97M | 650.4M | 653.54M | 584.15M | 547.59M | 458.23M | 407.93M |
| Equity Growth % | 0.23% | -0.44% | -0.31% | 1.61% | 2.9% | 0% | -0.11% | -0.06% | -0.16% | -0.11% |
| Book Value per Share | 8.85 | 4.03 | 2.68 | 6.10 | 22.29 | 22.32 | 20.38 | 19.23 | 16.58 | 15.13 |
| Total Shareholders' Equity | 226.12M | 177.67M | 214.3M | 275.51M | 668.04M | 669.75M | 593.51M | 542.22M | 464.07M | 414.71M |
| Common Stock | 4.52M | 4.61M | 4.68M | 5.38M | 5.41M | 5.42M | 5.44M | 5.46M | 5.46M | 4.86M |
| Retained Earnings | -111.42M | -160.34M | -127.87M | -167.69M | 254.44M | 260.43M | 199.87M | 149.52M | 83.82M | 32.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26.49M | -44.63M | -46.86M |
| Accumulated OCI | -1.05M | -2.24M | -3.88M | -6.07M | -18.28M | -23.58M | -39.61M | -14.39M | 129.15M | 133.96M |
| Minority Interest | -62.07M | -85.25M | -150.31M | -108.53M | -17.64M | -16.21M | -9.37M | 5.37M | -5.83M | -6.77M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -28.61M | -58.03M | -88.69M | -72.8M | -98.16M | -131.83M | -158.27M | -178.79M | -105.92M | -134.37M |
| Operating CF Margin % | -2.44% | -13.1% | -136.44% | -4.45% | -11.3% | -15.8% | -15.86% | -85.55% | -31.81% | -27.83% |
| Operating CF Growth % | -1.71% | -1.03% | -0.53% | 0.18% | -0.35% | -0.34% | -0.2% | -0.13% | 0.41% | -0.27% |
| Net Income | -58.24M | -81.61M | -70.7M | -70.66M | 366.06M | 4.57M | -62.71M | -37.06M | -65.7M | 27.78M |
| Depreciation & Amortization | 740K | 1.57M | 2.1M | 2.78M | 6.67M | 6.64M | 7.29M | 8.89M | 4.93M | 3.57M |
| Stock-Based Compensation | 11.1M | 10.15M | 11.85M | 12.64M | 14.47M | 10.72M | 13.95M | 14.7M | 4.42M | 22.85M |
| Deferred Taxes | -383K | -783K | -116.81M | -19.42M | -546.61M | -151.35M | -112.61M | -70.12M | 0 | 0 |
| Other Non-Cash Items | 13.37M | 10.7M | 81.9M | -8.1M | 46.23M | 6.11M | -5.05M | -111.12M | -67.09M | -178.34M |
| Working Capital Changes | 4.81M | 1.94M | 2.97M | 9.96M | 15.03M | -8.53M | 861K | 15.92M | 17.52M | -10.24M |
| Change in Receivables | 1.11M | 581K | -1.67M | 467K | 747K | -529K | -617K | -7.73M | 9.75M | 629K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | -103K | 0 | 0 | 0 |
| Change in Payables | 4.32M | 3.52M | 5.24M | 5.09M | 11.17M | 605K | 8.34M | 22.03M | 3.84M | -9.7M |
| Cash from Investing | -184.24M | -43.23M | 83.68M | -39.65M | 63.66M | 364.48M | 197.38M | -107.22M | 68.99M | 240.89M |
| Capital Expenditures | -4.61M | -3.68M | -2.17M | -4.49M | -12.54M | -5.42M | -5.66M | -2.18M | -245K | -11K |
| CapEx % of Revenue | 0.39% | 0.83% | 3.34% | 0.27% | 1.44% | 0.65% | 0.57% | 1.04% | 0.07% | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.16M | -39.55M | -16.34M | 125K | 191K | 350K | -14.91M | 416K | 865K | 255K |
| Cash from Financing | 285.94M | 29.49M | 14.7M | 156.89M | 49.91M | 38.87M | 22.73M | -29.83M | 78.14M | -16.96M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | -91K | -8K | -112K | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 284.46M | 27.16M | 0 | 150.96M | -1.68M | -2.91M | 33.84M | -4.07M | 99.98M | 93.1M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -33.22M | -61.71M | -90.86M | -77.29M | -110.69M | -137.25M | -163.94M | -180.97M | -106.16M | -134.38M |
| FCF Margin % | -2.83% | -13.93% | -139.78% | -4.72% | -12.74% | -16.45% | -16.43% | -86.59% | -31.88% | -27.83% |
| FCF Growth % | -2.03% | -0.86% | -0.47% | 0.15% | -0.43% | -0.24% | -0.19% | -0.1% | 0.41% | -0.27% |
| FCF per Share | -1.79 | -2.69 | -3.80 | -2.82 | -3.79 | -4.69 | -5.72 | -6.36 | -3.84 | -4.98 |
| FCF Conversion (FCF/Net Income) | 0.73x | 1.19x | -2.87x | 1.67x | -0.23x | -22.03x | 2.61x | 3.55x | 1.61x | -2.51x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -26.46% | -38.05% | 39.47% | -37.8% | 103.05% | 0.92% | -9.79% | -8.9% | -13.06% | 12.36% |
| Return on Invested Capital (ROIC) | -95.55% | -156.94% | -491.73% | -255.4% | -32.78% | -20.29% | -45.31% | -48.18% | -29.75% | -46.17% |
| Gross Margin | 93.7% | 64.57% | -10828.46% | -372.8% | -888.12% | 100% | -1007.03% | -6546.17% | -48.14% | 26.04% |
| Net Margin | -335.55% | -1101.15% | 4749.08% | -266.65% | 4847.42% | 71.75% | -606.85% | -2409.33% | -1972.88% | 1108.33% |
| Debt / Equity | 0.03x | 0.08x | 0.12x | 0.07x | 0.06x | 0.12x | 0.09x | 0.09x | 0.06x | 0.05x |
| Interest Coverage | -10.03x | -10.86x | -11.30x | -7.03x | -33.01x | -40.57x | -31.88x | -50.04x | -10.84x | -13.56x |
| FCF Conversion | 0.73x | 1.19x | -2.87x | 1.67x | -0.23x | -22.03x | 2.61x | 3.55x | 1.61x | -2.51x |
| Revenue Growth | 483.5% | -62.26% | -85.33% | 2418.62% | -46.93% | -3.99% | 19.64% | -79.06% | 59.33% | 44.98% |
PureTech Health plc (PRTC) has a price-to-earnings (P/E) ratio of 9.5x. This may indicate the stock is undervalued or faces growth challenges.
PureTech Health plc (PRTC) reported $6.3M in revenue for fiscal year 2024. This represents a 20% decrease from $7.9M in 2012.
PureTech Health plc (PRTC) grew revenue by 45.0% over the past year. This is strong growth.
PureTech Health plc (PRTC) reported a net loss of $31.5M for fiscal year 2024.
PureTech Health plc (PRTC) has a return on equity (ROE) of 12.4%. This is reasonable for most industries.
PureTech Health plc (PRTC) had negative free cash flow of $220.4M in fiscal year 2024, likely due to heavy capital investments.